Anne Dowdle v. HHS - Influenza, Guillain-Barré Syndrome (GBS) and/or chronic inflammatory demyelinating polyneuropathy (CIDP) (2023)
Case summary [AI summaries can sometimes make mistakes]
Anne Dowdle filed a petition for compensation under the National Vaccine Injury Compensation Program on September 14, 2020. She alleged that she suffered from Guillain-Barré Syndrome (GBS) and/or chronic inflammatory demyelinating polyneuropathy (CIDP) as a result of receiving the influenza vaccine on October 27, 2017, and that she experienced residual effects of this injury for more than six months.
The respondent denied that the flu vaccine caused her conditions. However, both parties agreed to settle the case through a stipulation filed on May 30, 2023.
Chief Special Master Brian H. Corcoran reviewed the stipulation and found it reasonable, adopting it as the decision in awarding damages.
The stipulation awarded Anne Dowdle a lump sum of $185,000.00, representing compensation for all damages available under the Act. Judgment was to be entered accordingly.
The public decision does not describe the specific onset of symptoms, medical tests, treatments, or expert witnesses. The attorneys involved were Lisa A.
Roquemore for the Petitioner and Naseem Kourosh for the Respondent.